|
Volumn 99, Issue 23, 2007, Pages 1748-1749
|
New NSCLC staging raises treatment issues.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TUMOR MARKER;
ADJUVANT CHEMOTHERAPY;
CANCER STAGING;
EUROPE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METASTASIS;
NOTE;
PATHOLOGY;
PREDICTION AND FORECASTING;
UNITED KINGDOM;
UNITED STATES;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
EUROPE;
GREAT BRITAIN;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM STAGING;
PREDICTIVE VALUE OF TESTS;
TUMOR MARKERS, BIOLOGICAL;
UNITED STATES;
|
EID: 38449119042
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djm259 Document Type: Note |
Times cited : (3)
|
References (0)
|